Cargando…
Update on Classic and Novel Approaches in Metastatic Triple-Negative Breast Cancer Treatment: A Comprehensive Review
Triple-negative breast cancer (TNBC) accounts for almost 15% of all diagnosed breast cancers and often presents high rates of relapses and metastases, with generally poor prognosis despite multiple lines of treatment. Immunotherapy has radically changed the approach of clinicians towards TNBC in the...
Autores principales: | Greco, Salvatore, Fabbri, Nicolò, Spaggiari, Riccardo, De Giorgi, Alfredo, Fabbian, Fabio, Giovine, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296377/ https://www.ncbi.nlm.nih.gov/pubmed/37371867 http://dx.doi.org/10.3390/biomedicines11061772 |
Ejemplares similares
-
Pathological Complete Response to Neoadjuvant Chemoimmunotherapy for Early Triple-Negative Breast Cancer: An Updated Meta-Analysis
por: Rizzo, Alessandro, et al.
Publicado: (2022) -
Rapid Assessment of COVID-19 Mortality Risk with GASS Classifiers
por: Greco, Salvatore, et al.
Publicado: (2023) -
The Role of Circulating Tumor Cells in the Prognosis of Metastatic Triple-Negative Breast Cancers: A Systematic Review of the Literature
por: Lisencu, Lorena Alexandra, et al.
Publicado: (2022) -
Comprehensive Geriatric Assessment for Older Women with Early-Stage (Non-Metastatic) Breast Cancer—An Updated Systematic Review of the Literature
por: Reid-Agboola, Chantae, et al.
Publicado: (2023) -
Cancer Vaccines for Triple-Negative Breast Cancer: A Systematic Review
por: Hosseini, Mina, et al.
Publicado: (2023)